The Patent Finder

Pfizer Enterprises SARL

Also on record
Records under this name other than patents Pfizer Enterprises SARL holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 9 of 9 · Back to Pfizer Enterprises SARL

PatentTitleStatus Expires Confidence
US 6,794,370Method for Treating Cancer Using Camptothecin Derivatives and 5-Fluorouracil
Formerly held
Term ended
Ended no later than May 1, 2020 · Low confidence
Term endedEnded no later than May 1, 2020Low confidence
US 6,403,569Method for treating cancer using camptothecin derivatives and 5-fluorouracil
Term ended
Term ended Apr 28, 2020 · From the USPTO record
Term endedTerm ended Apr 28, 2020From the USPTO record
US 6,664,242Composition and Method Comprising CPT-11 and a Pyrimidine Derivative for the Treatment of Cancer
Lapsed on the fee record
Ended Dec 16, 2011 · High confidence
Lapsed on the fee recordEnded Dec 16, 2011High confidence
US 6,562,834Combination Comprising Camptothecin and a Stilbene Derivative for the Treatment of Cancer
Lapsed on the fee record
Ended May 13, 2011 · High confidence
Lapsed on the fee recordEnded May 13, 2011High confidence
US 6,548,488Composition Comprising Camptothecin or a Camptothecin Derivative and an Alkylating Agent for the Treatment of Cancer
Lapsed on the fee record
Ended Apr 15, 2011 · High confidence
Lapsed on the fee recordEnded Apr 15, 2011High confidence
US 6,503,889Composition Comprising Camptothecin and a Pyrimidine Derivative for the Treatment of Cancer
Lapsed on the fee record
Ended Jan 7, 2011 · High confidence
Lapsed on the fee recordEnded Jan 7, 2011High confidence
US 6,500,953Preparation of Camptothecin and Nothapodytine Derivatives
Lapsed on the fee record
Ended Dec 31, 2010 · High confidence
Lapsed on the fee recordEnded Dec 31, 2010High confidence
US 6,486,320Preparation of Camptothecin and of Its Derivatives
Lapsed on the fee record
Ended Nov 26, 2010 · High confidence
Lapsed on the fee recordEnded Nov 26, 2010High confidence
US 6,476,043Use of Camptothecin Derivatives, with Reduced Gastrointestinal Toxicity
Lapsed on the fee record
Ended Nov 5, 2010 · High confidence
Lapsed on the fee recordEnded Nov 5, 2010High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited